SynthesisPharmacoEconomics2023

A Systematic Review of Cost-Effectiveness Studies of Newer Non-Insulin Antidiabetic Drugs: Trends in Decision-Analytical Models for Modelling of Type 2 Diabetes Mellitus.

Henrik Vitus Bering Laursen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.